OLX Group Reports Strong FY 2025 Results With 18% Revenue Growth and 61% Profit Uplift Year-on-Year
23.6.2025 09:00:00 CEST | Business Wire | Press Release
OLX Group (“OLX”), a global online classifieds leader and subsidiary of Prosus N.V., has reported strong financial results in the fiscal year 20251. The company generated revenues of US$7772 million, an 18% year-on-year increase. Adjusted EBIT3 (aEBIT) amounted to US$2702 million, representing an increase of 61% (in local currency) over the prior year, while aEBIT margin was 35%, a significant expansion from 25% in FY24.
The strong performance was primarily driven by its core categories Motors, Real Estate, and Jobs, in its key high-growth markets. In addition, the company continues to leverage its strong investments in product, with emphasis on enhancing the customer and user experience through state-of-the-art AI solutions.
Main categories essential for driving growth and profitability
Across its platforms, OLX witnessed strong user and customer engagement. OLX platforms, operating nine brands in nine markets worldwide, hosted nearly 64 million active listings daily, with 29 million monthly app users, highlighting the platform’s impressive scale and impact. In particular, Motors, Real Estate, and Jobs categories performed exceptionally well:
- Motors: Achieved 24% revenue growth year-on-year, driven by innovative dealer tools and trust-building features like vehicle history reports and ratings. OLX continues to make buying and selling cars safer and more efficient.
- Real Estate: Delivered 23% revenue growth year-on-year, supported by product enhancements like unified platform rollout, redesigned mobile app, and tools optimised for agents. Investment in tools for professionals is unlocking significant growth potential.
- Jobs: OLX strengthened its presence in key blue and grey collar job markets across Poland, Romania, and Ukraine, with investments in employer branding features and AI-powered matching capabilities. OLX Jobs continues to accelerate and expand rapidly.
Christian Gisy, CEO of OLX Group, said: “I am very happy with our financial performance in the fiscal year 2025. We are seeing strong, profitable growth momentum in all of our key categories and markets. This proves that we made the right strategic shift towards a stronger focus on our core B2C businesses Motors, Real Estate, and Jobs - in selected, high-growth markets. Our investments in Artificial Intelligence are starting to pay off and will enable us to leverage our potential for even more profitable growth in the future. Looking ahead, we are more than confident to achieve a sustained revenue growth of over 20%, with profit margins approaching 50% and more.”
Fabricio Bloisi, CEO of Prosus Group, said: “OLX has delivered another set of outstanding results, further demonstrating its position as a classifieds leader across multiple markets. As a core part of our lifestyle ecommerce ecosystem, OLX is making buying and selling simpler, smarter, and more trusted for millions of users. The team's clear strategy and performance demonstrate the company's momentum and I'm excited to see what Christian and the team achieve next.”
Pioneering in AI to improve customer and user experience and accelerate growth
With its focus on attractive, high-margin categories in fast-growth markets, data and AI-driven value-adding services for its customers, OLX has a strong strategy in place to further accelerate its growth trajectory.
To this end, OLX continuously invests in state-of-the-art AI solutions. In the past year, OLX invested over US$ 17M to further strengthen AI capabilities, tools, and talent base. On the back of the work of OLX’s data and AI teams, the company has deployed to date 55 AI use cases across the business, enhancing personalisation, trust, and automation both for users and professional customers. From smarter search, platform moderation, and fraud protection, AI will continue to be a crucial pillar of OLX’s growth strategy.
About OLX Group
OLX is a global marketplace leader that builds platforms to facilitate trade. Serving tens of millions of people around the world every month, OLX exists to enable buyers to afford things they would not usually buy as new, and to enable sellers to make extra cash and generate their own revenue stream.
OLX is the classifieds business of Prosus, one of the largest technology investors in the world. Operating and investing globally in markets with long-term growth potential, Prosus builds leading consumer internet companies that empower people and enrich communities.
For more information on OLX, visit www.olxgroup.com. For more on Prosus, its companies and investments, visit www.prosus.com.
1 April 2024 to March 2025
2 Includes financial results from OLX Autos business which was carved out but included in our continuous operations due to IFRS requirement
3 Adjusted EBIT = represents operating profit/loss from continuing operations adjusted to include lease interest paid and exclude the amortisation of intangible assets, retention option expenses and other losses/gains linked to business combinations and acquisitions, due diligence and legal fees, fair-value adjustments of financial instruments and/or impairment losses.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250623981963/en/
Contacts
Media Contact:
Ana Garcia | media@olx.com
FGS Global | olx_eu@fgsglobal.com
(c) 2024 Business Wire, Inc., All rights reserved.
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
BeOne Presents Compelling Data in Hard-to-Treat Liver and Lung Cancers at ESMO 202624.10.2026 10:15:00 CEST | Press Release
BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new data from multiple differentiated investigational medicines across its priority solid tumor disease areas at the European Society for Medical Oncology (ESMO) Congress 2026 (October 23–27, Madrid). The presentations span gastrointestinal, lung, and breast cancers, and reflect the growing momentum of BeOne’s solid tumor franchise. Mark Lanasa, M.D., Ph.D., Chief Medical Officer, Solid Tumors at BeOne, said: “At ESMO, we are showing how our strategy of matching the right modality to disease biology is translating into meaningful clinical progress. Our GPC3 x 4-1BB bispecific antibody continues to be well tolerated and demonstrates durable activity with longer follow up in patients with heavily pre-treated hepatocellular carcinoma, while the first clinical data from our brain-penetrant PRMT5 inhibitor and CEA-targeting ADC expand our innovation in non-small cell lung cancer. Alongsi
Phase 3 RAINIER Results Supporting Best-in-Class Potential of Povetacicept in IgA Nephropathy Published in the New England Journal of Medicine and Presented at the American Society of Nephrology Kidney Week 202623.10.2026 19:42:00 CEST | Press Release
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced the publication of Phase 3 RAINIER results for povetacicept in the New England Journal of Medicine (NEJM), presentation of these data at the American Society of Nephrology (ASN) Kidney Week 2026 in Denver, Colorado, and advancement of the povetacicept clinical research program in IgAN. Vertex will also host an investor event during ASN on October 23 at 6:15-7 p.m. MDT (8:15-9 p.m. EDT). Further details are below. Data being presented include a pre-specified Week 36 interim analysis of the ongoing Phase 3 RAINIER trial of povetacicept, an engineered fusion protein and dual inhibitor of the BAFF (B cell activating factor) and APRIL (a proliferation inducing ligand) cytokines, in immunoglobulin A nephropathy (IgAN). RAINIER met its primary endpoint, with povetacicept achieving a 52.0% reduction from baseline in proteinuria at Week 36 and a statistically significant and clinically meaningful 49.8% reduction versus placebo (
Lifezone Metals Confirms Advanced Negotiations with Orion CMC on Kabanga Nickel Project23.10.2026 16:19:00 CEST | Press Release
Lifezone Metals Limited (NYSE: LZM) notes comments made today by Oskar Lewnowski, Founder and Group Chief Executive of Orion Resource Partners, in an interview with Bloomberg Television regarding the Company’s Kabanga Nickel Project in Tanzania. In response to inbound inquiries from media outlets and investors following the interview, the Company can confirm that negotiations with Orion Critical Mineral Consortium (Orion CMC) regarding a significant equity investment into the Kabanga Nickel Project are at an advanced stage. The Orion CMC is a global investment platform launched by Orion Resource Partners in partnership with the U.S. International Development Finance Corporation (DFC) and Abu Dhabi's sovereign investor ADQ. As previously announced, the Company has been running a competitive process, led by Standard Chartered Bank, to secure a strategic investment into the Kabanga Nickel Project. Social Media LinkedIn | X | YouTube About Lifezone Metals Lifezone Metals (NYSE: LZM) is com
BeOne Medicines Reports Sustained Survival Benefit with TEVIMBRA-ZIIHERA Combination in First-Line HER2+ Gastroesophageal Cancer23.10.2026 16:15:00 CEST | Press Release
BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new survival results from the planned second interim analysis (IA2) and final formal analysis of the Phase 3 HERIZON-GEA-01 trial, further confirming the benefit of TEVIMBRA® (tislelizumab) plus ZIIHERA® (zanidatamab) and chemotherapy as first-line treatment for patients with HER2-positive locally advanced or metastatic gastroesophageal adenocarcinoma (GEA). The results will be presented today as a late-breaking abstract during a rapid oral session at the European Society for Medical Oncology (ESMO) Congress 2026 in Madrid, Spain (LBA79). Mark Lanasa, M.D., Ph.D., Chief Medical Officer, Solid Tumors at BeOne, said: “Following the U.S. approval in August, these longer-term data provide further evidence supporting TEVIMBRA plus ZIIHERA and chemotherapy as the new standard of care in all first-line HER2-positive advanced gastroesophageal adenocarcinoma patients, regardless of PD-L1 sta
inDrive and Pony.ai Announce Collaboration to Explore Autonomous Mobility in Kazakhstan Built on NVIDIA Hyperion23.10.2026 15:00:00 CEST | Press Release
inDrive, the global mobility and delivery platform, today announced it has signed a memorandum of understanding (MOU) with NVIDIA and Pony.ai, a global leader in the large-scale commercialization of autonomous driving technology, to explore the future of autonomous ride-hailing. Kazakhstan will serve as the first test market. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261023143469/en/ inDrive partners with Pony.ai and NVIDIA to explore autonomous mobility in Kazakhstan Kazakhstan was chosen first for its regulatory readiness following the creation of the country’s first structured legal framework for driverless transport, as part of its “Year of Digitalization and Artificial Intelligence.” Combined with Kazakhstan’s position as a leading Central Asian economy, this gives the companies a clear basis to assess autonomous ride-hailing in practice. The three companies will evaluate the technical, operational, regulatory and
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom